bibliographicCitation |
Wang H, Chi L, Yu F, Dai H, Si X, Gao C, Wang Z, Liu L, Zheng J, Ke Y, Liu H, Zhang Q. The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers. Bioorg Med Chem. 2022 Sep 15;70():116922. doi: 10.1016/j.bmc.2022.116922. PMID: 35849914. |